CareDx, Inc. (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
21.50
+0.69 (3.32%)
At close: May 1, 2026, 4:00 PM EDT
21.71
+0.21 (0.98%)
After-hours: May 1, 2026, 7:03 PM EDT

CareDx Revenue

CareDx had revenue of $117.70M in the quarter ending March 31, 2026, with 38.99% growth. This brings the company's revenue in the last twelve months to $412.82M, up 19.17% year-over-year. In the year 2025, CareDx had annual revenue of $379.81M with 13.79% growth.

Revenue (ttm)
$412.82M
Revenue Growth
+19.17%
P/S Ratio
2.69
Revenue / Employee
$539,634
Employees
765
Market Cap
1.11B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025379.81M46.02M13.79%
Dec 31, 2024333.79M53.46M19.07%
Dec 31, 2023280.32M-41.47M-12.89%
Dec 31, 2022321.79M25.40M8.57%
Dec 31, 2021296.40M104.20M54.22%
Dec 31, 2020192.19M65.13M51.25%
Dec 31, 2019127.07M50.50M65.95%
Dec 31, 201876.57M28.25M58.45%
Dec 31, 201748.32M7.69M18.93%
Dec 31, 201640.63M12.49M44.37%
Dec 31, 201528.14M838.00K3.07%
Dec 31, 201427.31M5.21M23.57%
Dec 31, 201322.10M1.65M8.05%
Dec 31, 201220.45M17.51M595.14%
Dec 31, 20062.94M2.62M799.69%
Dec 31, 2005327.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics824.50M
NeoGenomics745.97M
OPKO Health581.12M
Veracyte517.15M
GeneDx Holdings427.54M
Twist Bioscience391.56M
Castle Biosciences344.23M
Fulgent Genetics320.35M
Revenue Rankings